Gout

Japan-based pharmaceutical firm Eisai Co. has received approval for URECE Tablets (dotinurad) in Thailand as a treatment for gout and hyperuricemia. This approval is the first time that the agent has been approved in China or the five ASEAN (Association of Southeast Asian Nations) member states where Eisai holds licenses to develop and distribute the agent.

URECE Tablets are a new therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN. It suppresses uric acid reabsorption and lowers blood uric acid levels by selectively inhibiting the urate transporter (URAT1) related to reabsorption of uric acid in the kidney.

Thailand approves new therapeutic medicine for gout and hyperuricemia Thailand approves new therapeutic medicine for gout and hyperuricemia

Cheers to
Stage three ;)